The 4 analysts offering 12-month price forecasts for Alpine Immune Sciences Inc have a median target of 20.50, with a high estimate of 27.00 and a low estimate of 18.00. The median estimate represents a +107.70% increase from the last price of 9.87.
The current consensus among 5 polled investment analysts is to Buy stock in Alpine Immune Sciences Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.30
Reporting Date Mar 31
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.